期刊文献+

参附注射液对老年气虚血瘀型舒张性心力衰竭患者生存质量的影响 被引量:14

下载PDF
导出
摘要 目的观察参附注射液对老年气虚血瘀型舒张性心力衰竭患者生存质量的影响。方法将中医辨证为气虚血瘀型舒张性心力衰竭患者86例随机分成2组。对照组采取基础药物对症治疗,参附组在此基础上加用参附注射液,治疗前后测量2组6 min步行距离、中医症候群变化、生活质量一般性健康检查简易量表(SF-36),评价2组患者生存质量。结果参附组SF-36评分明显优于对照组和治疗前(P均<0.05),6 min步行距离较对照组和治疗前明显延长(P均<0.05),中医证侯较对照组和治疗前明显改善(P均<0.05)。结论参附注射液辅助治疗老年气虚血瘀型舒张性心力衰竭疗效好,可提高老年人生存质量。
出处 《现代中西医结合杂志》 CAS 2014年第10期1060-1061,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine
基金 河北省中医药管理局科研计划资金资助项目(20110037)
  • 相关文献

参考文献7

  • 1张子彬.左室舒张功能障碍性心力衰竭的诊断修订标准中国心力衰竭协会(CHFA)[J].心血管病学进展,2002,21(3):封二.
  • 2国家中医药管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:85-89.
  • 3Kass PA,Bronzwaer GF,Paulus WJ,et al.what mechanisms under-lie diastdic dysfunction in heart failure?[J].Circulation,2004,94(12):1533-1542.
  • 4Banerjee P,Clark AL,Cleland JGF,et al.Diastolic heart failure diffi-cult problem in the elderly[J].Am J Geriatr cardiol,2004,1:16-21.
  • 5龚开政,张振刚,朱宁,孙红光,凤以良.SF-36在慢性心力衰竭患者中的信度和效度评价[J].中国康复医学杂志,2004,19(3):182-184. 被引量:50
  • 6潘亮,潘蓉,王亮,等.参附注射液对家兔心肌缺血再灌注损伤保护作用[J].解放军药学杂志,2001,21(12):115-117.
  • 7张武新,潘港.参麦注射液、参附注射液治疗充血性心力衰竭临床疗效观察[J].现代中西医结合杂志,2007,16(9):1184-1185. 被引量:20

二级参考文献28

  • 1霍根红.试论充血性心力衰竭的中医病理实质[J].河南中医,1996,16(5):274-276. 被引量:30
  • 2Mc Homey CA, Ware J, Raczek AE.The MOS 36-item ShortForm Health Survey (SF-36):Ⅱ Psychometric and clinical tests of validity in measuring physical and mental health constructs[J].Med Care,1993,31 (3):247-263.
  • 3Jenkinson C, Jenkinson D, Shepperd S,et al.Evaluation of treatment for congestive heart failure in patients aged 60 years and older using generic measures of health status(SF-36 and COOP charts)[J].Age Ageing,1997.26(l):7-13.
  • 4Westlake C,Dracup K,Creaser J,et al.Correlates of health-related quality of life in patients with heart failure[J].Heart Lung,2002.31(2): 85-93.
  • 5Ekman L Fagerberg B,Lundman B.Health-related quality of life and sense of coherence among elderly patients with severe chronic heart failure in comparison with healthy controls[J].Heart Lung,2002,31(2):94-101.
  • 6Konstam V.Salem D,Pouleur H,et al. Baseline quality of life as a predictor of mortality and hospitalisation in 5,025 patients with congestive heart failure [J].Am J Cardiol.1996,78(8):890-895.
  • 7Wiklund I, Waagstein F, Swedberg K, et al. Quality of life on treatment with metoprolol in dilated cardiomyopathy results from the MDC Trial. Metoprolol in Dilated Cardiomyopathy Trial[J].Cardiovasc Drugs Ther,1996,10(3):361-368.
  • 8Cohn JN, Fowler MB, Bristow MR. et al. Safety and efficacy of earvedilol in severe heart failure.The US Carvedilol Heart Failure Study Group[J].J Card Fail,1997,3(3):173-179.
  • 9Brown N,Melville M.Gray D,et al.Quality of life four years after acute myocardial infarction:short form 36 scores compared with a normal population[J].Heart,1999.81(4):352-358.
  • 10Ware JE. Gandek B.Overview of the SF-36 health survey and the international quality of life assessment(IQOLA) project[J].J Clin Epidemiol,1998,51(11):903-912.

共引文献260

同被引文献413

引证文献14

二级引证文献191

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部